Puneet Souda's Stock Ratings

Leerink Partners Analyst

Puneet Souda is an analyst at Leerink Partners. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 08/01/2024

Overall Average Return

-2.24%

Smart Score

55.3%

Overall Average Return Percentile

31st

Number of Ratings

112
Data brought to you by Benzinga APIs

Recent Analyst Stock Rating News

These Analysts Revise Their Forecasts On Waters After Q2 Results
What Analysts Are Saying About Waters Stock
Meta To Rally Around 35%? Here Are 10 Top Analyst Forecasts For Thursday
Key Takeaways From Myriad Genetics Analyst Ratings
Agilent To $165? These Analysts Boost Price Targets On The Lab Tools Firm Following Upbeat Q3 Earnings
Agilent Technologies, Inc. (NYSE: A) reported better-than-expected Q4 results.
Wingstop To Rally Around 13%? Plus This Analyst Cuts PT On Cano Health By 50%
  Wedbush boosted the price target on Wingstop Inc. (NASDAQ: WING) from $157 to $177. Wedbush analyst Nick Setyan maintained an Outperform rating on the stock. Wingstop shares rose 0.8% to $156.66 on Thursday.
Why This Illumina Analyst Is Bullish About NovaSeq X+
Illumina, Inc.’s (NASDAQ: ILMN) NovaSeq X Plus is likely to become “the ultimate genome machine,” lending upside in 2024 and beyond, according to SVB Securities.
Know The 2 Healthcare Companies Cathie Wood's Ark Invest Bought On Friday
Cathie Wood's Ark Invest may have had a disappointing 2021, but the fund's purchases/liquidations are always watched keenly by investors.
Guardant Health Will Not Go With NeoGenomics Deal: Bloomberg
Illumina Completes Grail Buyout Despite Uncertainty In Regulatory Process
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free